Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C1 Inhibitor Treatment Registry to Assess the Safety and Immunological Profile of Ruconest in the Treatment of HAE Attacks

NCT01397864 is registered in ClinicalTrials.gov with Pharming Technologies B.V. as lead sponsor.

NCT NCT01397864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C1 Inhibitor Treatment Registry to Assess the Safety and Immunological Profile of Ruconest in the Treatment of HAE Attacks
Lead sponsor
Pharming Technologies B.V.
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
December 10, 2024
Enrollment
181 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema